Index
- Introduction
- History
- Overview of normal human haematopoiesis
- Properties of B Cell
- Types of B cell
- B Cell Surface Protein
- B Cell Development
- B Cell Maturation
- B Cell Activation & differentiation
- B Cell Selection
- Types of Selection – Positive and Negative
- Importance of Cell Selection
- Summary
- Reference
Introduction
B cell or B lymphocyte is a type
of lymphocyte (white blood cells) involved in the humoral immunity of
the adaptive immune system as they differentiate into plasma and produce
antibodies.
· Besides, B cells are also considered
professional antigen-presenting cells as these can detect antigens present on
the surface of bacteria and viruses.
· Like in all white blood cells, B lymphocytes
are also generated in the bone marrow, which is then exported to the periphery.
· Every day, millions of B lymphocytes are
produced in the bone marrow, and the rapid generation of these
cells is carefully monitored by a regulated sequence of events.
· B cells are fewer in number than T cells as these
account for about 20% of the blood lymphocytes in the body, whereas the
rest are T cells.
· B cells are essential cells of the immune system since these
are a part of the humoral or antibody-mediated immunity essential for the
successful removal of antigens from the body.
· These cells have receptors on the surface known as B
cell receptors. The B cell receptor is a macromolecular complex that
is built with the help of IgM and IgD.
· Since the receptors are present on the surface, these
can detect antigens that occur on the surface of pathogens.
· Another distinguishing feature of B lymphocytes
is that these mature within the bone marrow, unlike T lymphocytes that
are moved to the thymus for maturation.
· The mature B cells occur outside the lymph
nodes, and these have a shorter lifespan and thus immediately mature to produce
antibodies.
· B cells do not act against tumors or transplants and also do
not move to the site of infection. Instead, they produce immunoglobulins that
move to the site of action.
History
The first indication of the
existence of B cells was in 1890 when Emil von Behring and Shibasaburo
Kitasato discovered that circulating “antitoxins” (now known to be
antibodies) were important in immunity to diphtheria and tetanus (von
Behring and Kitasato 1890). Paul Ehrlich later proposed that cells
with pre-formed antibody receptors (now known to be B cell receptors)
were the possible producers of these “antitoxins” (Ehrlich 1967)
Up until 1980, the molecular composition of the cell surface of B cells was largely uncharacterized, and the B cell surface was known to only consist of bound Ig, complement receptors and Fc receptors. This changed with the introduction of monoclonal antibody technology by Cesar Milstein in 1975. The first B cell specific molecule described was termed B1 and is now known as CD20.
Hematopoietic stem cells (HSCs)
develop into B cells through a multi-stage process called hematopoiesis that
occurs in the bone marrow:
· Hematopoietic stem cells differentiate into
multipotent progenitor cells
· Common lymphoid progenitor cells develop into B
cells, T cells, or natural killer cells
· B cell lineage pathway: B lymphocyte progenitor
gives rise to a Pre-Pro B Cell, a Pro-B Cell, and a Pre-B cell
· Immature B cell is generated
· Selection
process: Transitional B cells migrate to the spleen where they
undergo further rounds of differentiation until selection into the mature B
cell pool occurs
Fig: - Overview of normal human
haematopoiesis
Properties
of B-Cell
B cells, or B
lymphocytes,
are a type of white blood cell that play an important role in the immune
system. They are responsible for producing antibodies, which are proteins that
bind to specific antigens (foreign substances) and help to neutralize them. B
cells also play a role in antigen presentation, which is the process by
which antigens are displayed on the surface of cells so that they can be
recognized by other immune cells.
·
They are APCs
·
They can express MHC-II
·
They have surface marker or identification marker: - CD19
·
Antibodies at surface of B-Cell: - IgM
& IgD
·
Part of Adaptive Immunity (Cause humoral Immunity or
Antibodies mediated Immunity)
·
Location of origine & Maturation: - Bone Marrow
·
Maturation B-Cell have BCR (B-Cell
Receptor)
B cell (B lymphocyte) Types: -
·
B cells have been differentiated into four distinct
groups;
- Transitional
B cells
- Naïve
B cells
- Plasma
Cells
- Memory
cells
Transitional
B cells
- Transitional B cells are the
intermediate B cells that are the link between the immature B
cells in the bone marrow and mature B cells in the lymphoid
organs.
- Transitional B cells are the
cells that are differentiated from the myeloid progenitor cells in the
bone marrow but have not matured.
- Transitional B cells can be
found in the bone marrow, peripheral blood as well as spleen but only a
small fraction of the immature B cells can survive the transitional
phase before maturing into matured cells.
- After leaving the bone marrow, these cells are
subjected to a number of checks to ensure that they do not produce
autoantibodies.
- Transitional B cells can be
found in two transitional stages; T1 and T2. T1 stage
is the period between the migration of the cells from the bone marrow to
the point of entry into the spleen, whereas the T2 stage occurs
within the spleen, where the cells develop into mature B cells.
Naïve
B cells
- Naïve B cells are the mature B cells
that haven’t yet been exposed to antigens.
- Naïve B cells are the B cells at a stage of differentiation where the cells either develop into plasma cells or memory cells after exposure to a specific antigen.
- These cells occur in the secondary lymphoid
organs and have passed the transitional stage of B cell
development.
- Naïve B cells have recently divided into a new
subcategory of B cells called Breg cells or
regulatory B cells. These cells are paired with naïve T
cells and act in regulating the response of T cells.
Plasma Cells
- Plasma cells or plasma B cells,
or effector B cells are the white blood cells that are
differentiated from naïve B cells that secrete large quantities of
antibodies in response to activation by antigens.
- The production of plasma cells requires
that the naïve B cells present an antigen to a helper T cell.
This activates the T cell, which in turn activates the B cell.
- Some plasma cells can also be activated by a
second process called T-cell independent antigen stimulation. The plasma
cells produced by this method can only secrete IgM antibodies.
- The antibodies produced by plasma cells are
specific to the antigen initially processed by the naïve T cell
during activation. A plasma cell, thus, cannot secrete more than
one type of antibody.
- Plasma cells have a shorter lifespan as compared
to memory B cells, and these move through the body according to the
distribution of cytokines to produce antibodies closer to the site of
infection.
- Plasma cells are usually large in size with abundant cytoplasm and a characteristic eccentric nucleus. The differentiated plasma cells express fewer surface antigens like CD27++ but do not express CD19 and CD20.
- These cells occur in the secondary lymphoid
organs and have passed the transitional stage of B cell
development.
Fig: - Plasma cell & Memory
Cell
Memory
cells
- Memory B cells are lymphocyte that
are differentiated from naïve B cells during maturation and
circulate through the bloodstream in a stationary phase.
- The cause of differentiation of naïve cells
into plasma cells and memory cells is not yet understood.
- Memory B cells have a much longer
lifespan as these can move through the bloodstream for years.
- Memory B cells are distributed
throughout the body, and like plasma cells, these also have an
affinity for one type of antigen.
- The primary function of memory cells is that
these cells memorize the characteristics of the antigen that activated the
parent B cell so that if the memory cell encounters the
antigen again, it can trigger a stronger secondary immune response.
- Memory B cells are developed within the
germinal centers of lymphoid organs where the differentiation can occur
either by a T cell-dependent mechanism or a T cell-independent
mechanism.
- Following differentiation, memory B cells
might remain concentrated at certain areas in the body where they are more
likely to detect the antigens.
B cell development
- The initial stages of B cell development
occur within the complex microenvironments of the stromal cells of the
bone marrow called niches.
- The process is activated by stimuli and factors
that initiate a series of cell signals that cause the expression of
different target genes that modulate cell survival, proliferation, and
development.
- The development of B cell initiates with
hematopoietic stem cell, which is then transformed into an early lymphoid
progenitor and then a common lymphoid progenitor.
- The prerequisite for the development of B
cells is the absence or suppression of protein Notch-1 signaling
in the bone marrow.
- The overall development of B cells occurs
following the stages of maturation, activation, differentiation, and
memory generation.
Fig: - B
Cell development
Maturation
of B Cell
- Maturation is the first step of B cell
development within the bone marrow before traveling to other lymphoid
organs like the spleen and lymph nodes.
- The
development of immature B cells in the bone marrow can be described into
different stages, each of which is characterized by various gene
expression patterns and immunoglobulin H chain and L chain
gene arrangements.
Fig: - Maturation of B Cell
- During the development, B cells generate
various B cell receptors as a part of the selection process.
- The selection occurs via one of two mechanisms;
positive mechanisms occur via antigen-independent signaling where if the
receptors on the B cells do not bind to their ligands, the cells do
not receive proper signals and cease to develop.
- A negative selection mechanism occurs by the
binding of self-antigen to the BCR, where if the BCR can
bind strongly to a self-antigen, the development of B cells is
ceased.
- In order to complete development, immature B
cells migrate from the bone marrow into the spleen as transitional B
cells through the two stages; T1 and T2.
- The cells are considered T1 B cells
through their migration to the spleen and after entry into the spleen. In
the spleen, the T1 B cells mature into T2 B cells.
- The T2 B cells differentiate either into
follicular B cells or marginal zone B cells depending on the
signals received by the receptors on the cells.
- The cells are considered mature B cells or
naïve B cells after differentiation in the spleen.
Fig: -
Maturation of B Cell
Activation
of B cell
- B cell activation usually occurs in the spleen or other
secondary lymphoid organs like lymph nodes.
- After maturation in the bone marrow, the cells
migrate to lymphoid organs as they tend to have a constant supply
of antigen with the help of the circulating lymph. The migration is
induced by chemokine interaction between CXCL13 and CXCR5.
- The activation of B cells begins with
exposure to antigen via different receptors present on the surface like
the BCR receptors.
- The response of B cells upon detection of
antigen depends on the structure of the antigens.
T cell-dependent B cell response
- At the beginning of the T-dependent B cell
response, the B cells bind to the antigen via the Ig
receptors. Some of the antigens are internalized into specialized
vesicles within the B cells.
- The internalized antigens are processed and
re-expressed in the form of peptides presented in the antigen-binding
groove of class II MHC molecules.
- The T cells that have been previously
exposed to antigen-bearing dendritic cells can now bind to the MHC-presented
peptide on the surface of the B cell.
- The binding is further enhanced by the
interaction of accessory molecules on the T- and B-cell surfaces.
- Some of the T-cell-activated B cells now
move into specialized regions of the lymph node or spleen to
begin the process of differentiation.
Fig:
- T cell Dependent Activation
T cell-independent B cell response
- Activation of B cells can also occur
without the participation of T cells, and it produces a particular
subset of B cells that respond with antibody production to
particular classes of antigens.
- Antigens that elicit a T cell-independent antibody response tend to be polyvalent with repeating determinants shared among many microbial species. These antigens are called Tl antigens.
- The responses to these antigens are usually rapid even though antibodies generated by this method have lower affinity and are less functionally versatile than those activated by T cell-dependent methods.
- Like in the case of T cell-dependent activation, B cells activated by Tl antigens also require additional signals to attain complete activation.
- However, these cells receive the signals either by recognition and binding a microbial constituent to toll-like receptors or by extensive cross-linking of the B cell receptor epitopes to the bacterial or viral surfaces.
- The B cells activated by the T cell-independent method proliferate outside the lymphoid centers and undergo immunoglobulin class switching and differentiation.
Differentiation of B cell
- The differentiation of activated B cells
is stimulated by the interaction of the B cell receptors to specific
antigens.
- Some activated cells are moved into regions at
the border of the T cell and B cell areas known as primary
foci.
- At the primary foci, the cells undergo
differentiation into plasma cells in about four days
post-stimulation.
- The differentiation cells then migrate to the medullary cord regions of the node, where they secrete large quantities of antibodies.
- Post differentiation, some of the plasma cells die after the primary response, whereas others remain in the bone marrow or the gut as long-lived plasma cells.
- Some antigen-stimulated B cells, however, do not enter the primary foci but rather migrate to follicles on the lymph nodes or the spleen.
- As the B cells begin to differentiate, the follicles swell with antigen-specific lymphocytes, resulting in a germinal center’s appearance.
- At the end of the immune response, memory B cells remain that are the daughter cells of the cells stimulated during the response.
B Cell Selection
B cells are the key players in the adaptive immune system,
undergo a rigorous selection process to ensure they can effectively recognize
foreign antigens while ignoring the body’s own tissues. This selection occurs
primarily in the bone marrow during B cell development and involves both
positive and negative selection.
B cells undergo via these two key selection processes during
their development in the bone marrow, both centered on the B cell receptors
(BCR) present on their surface. Positive selection involves antigen-independent
signaling through the pre-BCR and BCR. If these receptors fail to
bind to their ligands, the B cells do not receive the necessary signals for
further development and their maturation halts. Negative selection occurs when
the BCR binds to self-antigens. If this binding is strong, the B cell
faces one of four outcomes: clonal deletion, receptor editing, anergy, or
ignorance (where the B cell continues to develop despite the signal).
This negative selection process ensures central tolerance, resulting in mature
B cells that do not recognize self-antigens in the bone marrow.
To fully mature, immature B cells leave the bone
marrow and migrate to the spleen as transitional B cells, progressing
through two stages: T1 and T2. They are classified as T1 B
cells during their migration and upon entering the spleen. Within the
spleen, T1 B cells transition into T2 B cells. These T2 B cells
then differentiate into either follicular (FO) B cells or marginal zone (MZ) B
cells, depending on signals received through the BCR and other
receptors. Once this differentiation is complete, they become mature, naïve
B cells.
Types of B Cell Selection:
B cell selection involves two main processes:
- Positive Selection: Ensures that B cells have successfully rearranged their immunoglobulin genes to express a functional BCR capable of recognizing antigens.
- Negative Selection: Eliminates or inactivates B cells that strongly recognize self-antigens, preventing autoimmunity.
Positive
Selection:
Positive
selection ensures that B cells capable of producing functional B cell
receptors (BCRs) survive and mature. This process begins with the
rearrangement of immunoglobulin genes to produce a diverse array of BCRs.
Immature B cells in the bone marrow express a pre-B cell receptor (pre-BCR)
and later a membrane-bound immunoglobulin M (IgM). Positive selection
occurs when these receptors successfully bind to antigen-presenting cells or
self-antigens, providing the necessary survival signals. B cells that do
not receive these signals undergo apoptosis, while those that do are allowed to
progress to the next developmental stage. This step is crucial for creating a
diverse B cell repertoire capable of recognizing various pathogens.
Fig: Positive Selection of B Cells
B cell
survival and progression through developmental stages are regulated by signals
delivered through membrane pre-B receptors and membrane IgM. This
can be explained by two types of experiments:
2. Knock-out Mouse Experiments: Knock-out mice, which lack specific genes or gene
components, have shown the crucial role of membrane expression in B cell
development. Mice deficient in H chain transmembrane exons, Iga or Igb
genes (or just their ITAMs), or surrogate light chains (l5 and VpreB)
fail to develop B cells despite the presence of other necessary proteins. The
surrogate light chain l5, mimicking the constant region of light chains,
associates with VpreB, which resembles an Ig V domain. This interaction is
hypothesized to provide a signal for pre-B cell proliferation and subsequent
light chain recombination.
Allelic
Exclusion and Light Chain Isotypic Exclusion: Somatic recombination results in allelic exclusion, where each B cell
successfully recombines only one H chain and one L chain gene. In
heterozygotes, each allele is represented in approximately half of B cells and
serum immunoglobulins. Light chains also exhibit isotypic exclusion, meaning
each B cell or immunoglobulin molecule contains only k or λ
chains. The proportion of k to λ chains varies among species,
reflecting the number of V region segments and their recombination
efficiency.
Post-Marrow
B Cell Survival: After
exiting the bone marrow, B cells rely on signals in secondary lymphoid tissues
for survival. These signals are thought to be delivered in lymphoid follicles,
where competition for survival signals among B cells helps maintain
homeostasis. For instance, survival of transgenic B cells (marked by
unique receptors) has been shown to depend on the depletion of the host's
normal B cells through irradiation, emphasizing the role of competitive
signaling in B cell maintenance.
Negative
Selection:
Negative
selection, on the other hand, is a critical process for eliminating or
inactivating self-reactive B cells to prevent autoimmunity. Immature B cells
that express IgM on their surface are exposed to self-antigens within the bone
marrow. If these B cells bind strongly to multivalent self-antigens,
they undergo clonal deletion, leading to apoptosis. This removes self-reactive
B cells that could potentially attack the body’s own tissues. For B cells that
bind to soluble self-antigens, they become anergic—functionally inactive and
unable to mount an immune response allowing them to migrate to peripheral
lymphoid organs without causing autoimmunity.
Fig: B Cell Negative Selection Checkpoints
Negative
selection is a crucial mechanism in B cell development that ensures the immune
system avoids attacking the body’s own tissues. This process is essential for
maintaining self-tolerance and preventing autoimmune diseases. Negative
selection operates with following processes.
1. Binding
to Multivalent Self-Ligands:
Mechanism: Immature B
cells in the bone marrow express immunoglobulin M (IgM) on their surface. When
these B cells encounter multivalent self-antigens—antigens that are strongly
cross-linked on cell surfaces—they receive a signal indicating potential
self-reactivity. This strong binding triggers the cell to undergo apoptosis
(programmed cell death) and clonal deletion. This step ensures that B cells
with receptors highly reactive to self-antigens are removed before they can
enter the peripheral blood.
Purpose: The
removal of these self-reactive B cells prevents the development of autoimmunity
by eliminating cells that would otherwise attack the body's own tissues.
2. Binding
to Soluble Self-Antigens:
Mechanism: B cells that bind to soluble self-antigens—antigens not attached to cell surfaces—do not undergo apoptosis. Instead, these B cells become anergic, meaning they are functionally inactivated and unable to mount an immune response. These anergic cells express low levels of IgM and high levels of IgD and have a shortened lifespan.
Purpose: By
rendering these self-reactive B cells non-functional, the immune system
prevents them from contributing to an autoimmune response while allowing them
to migrate to peripheral tissues where they can potentially encounter non-self-antigens.
3. Survival
and Maturation in the Periphery:
Mechanism: B cells
that do not bind to self-antigens in the marrow mature and exit to secondary
lymphoid organs, such as the spleen and lymph nodes. These cells express both
IgM and IgD and can survive in lymphoid follicles for several weeks. They
continue to circulate until they either encounter their specific antigen or
die.
Purpose: This
ensures that the B cell repertoire is diverse and capable of responding to a
wide range of pathogens. B cells that do not encounter their target antigen
will eventually undergo apoptosis, maintaining a balance within the immune
system.
4. Receptor
Editing:
Mechanism: For some B cells that initially bind self-antigens,
receptor editing provides an opportunity for rescue. During receptor editing,
the B cell undergoes additional somatic recombination of its immunoglobulin
genes to generate new heavy (H) and light (L) chain combinations. This process
alters the specificity of the B cell receptor (BCR) so that it no longer
recognizes self-antigens. In experimental models, such as mice with
self-MHC-specific BCRs, receptor editing has shown that B cells can adjust
their specificity and avoid self-reactivity.
Purpose: Receptor
editing allows self-reactive B cells to be rescued by changing their antigen
specificity, thereby preventing autoimmunity and maintaining a diverse B cell
repertoire.
5. Gene
Conversion:
Mechanism: In species
with low germline diversity, where limited V, D, and J gene segments are
available, immature B cells may bind self-antigens due to insufficient
diversity. During development, these cells undergo cell division in response to
self-antigen binding. Gene conversion occurs, where DNA from adjacent
pseudogenes (gene segments containing stop codons) is incorporated into the Ig
genes, leading to altered V region sequences and increased diversity.
Purpose: Gene
conversion helps generate a diverse array of Ig V regions, allowing B cells to
escape self-reactivity and mature properly. This compensates for the limited
germline diversity and ensures the development of a functional B cell
repertoire.
Fig: B Cell Negative Selection during bone marrow maturation
Key Signaling Pathways in B Cell
Selection
· BCR
Signaling Pathway: The BCR
complex, which includes the surface IgM and the Igα/Igβ heterodimers, initiates
signaling cascades upon antigen binding. These cascades involve key molecules
like Lyn, Syk, PI3K, and BTK, which ultimately influence the cell's fate
(survival, deletion, or anergy).
· Role of
Co-Receptors:
Co-receptors such as CD19, CD21, and CD81 modulate BCR signaling. For example,
CD19 amplifies BCR signaling, while CD22, a negative regulator, dampens it. The
balance of these signals determines whether a B cell receives survival signals
or undergoes negative selection.
· Cytokines
and Growth Factors: The bone
marrow microenvironment provides various cytokines and growth factors (e.g.,
IL-7, BAFF) that support B cell development and modulate the selection
processes. IL-7 is particularly crucial during the early stages of B cell
development, promoting survival and proliferation.
Abnormalities due to B-cell selection:
1. Autoimmunity
B-cell selection is tightly regulated through checkpoints in both the bone marrow and peripheral lymphoid tissues. In the periphery, B cells undergo a secondary screening to ensure they don't react with self-antigens, leading to apoptosis, receptor editing, or anergy if they do. This process produces a diverse population of B cells capable of producing high-affinity antibodies, free ofharmful autoreactivity. However, when the balance between activating and inhibitory signals is disrupted, it can lead to the production of autoantibodies and the development of autoimmune diseases.
Autoantibodies,
mistakenly targeting the body's own tissues, became recognized as hallmarks of
autoimmune diseases like rheumatoid arthritis in the mid-20th century. The discovery
of autoantibodies in conditions like glomerulonephritis provided early evidence
of disease caused by ongoing antigen-antibody reactions. Although the link
between autoantibodies and autoimmune diseases is clear, the exact role they
play in disease pathogenesis is still not fully understood.
Disruptions
in apoptotic regulation, as seen in Bcl-2 transgenic mice, can lead to the
survival of autoreactive B cells, resulting in autoimmune conditions like
systemic lupus erythematosus (SLE). Environmental factors and genetic mutations
also contribute to autoimmune disease by dysregulating B-cell function.
With a
better understanding of B cells' role in autoimmune diseases, more targeted
therapies like Rituximab have been developed. Rituximab reduces B-cell numbers
with minimal toxicity and is used to treat rheumatoid arthritis and other
autoimmune conditions. Additionally, the BAFF/BlyS cytokine, critical for
B-cell survival, offers another therapeutic target, with elevated BAFF levels
being linked to SLE, suggesting that disrupting BAFF function could be
beneficial in treating autoimmune diseases.
2. Immunodeficiency
The
significance of genes involved in pre-B cell receptor (pre-BCR) signaling and
downstream pathways has been clearly demonstrated through studies of
gene-targeted mice and patients with primary immunodeficiencies. One
well-researched example is the Bruton tyrosine kinase (BTK) gene, which, when
mutated, causes X-linked agammaglobulinemia (XLA). XLA was first identified in
a male patient who experienced recurrent bacterial infections and had
undetectable serum immunoglobulin levels. XLA patients exhibit a block at the
transition from pro-B cells to large pre-B cells in the bone marrow and have a
marked reduction in peripheral blood B cells. BTK is crucial for signaling
downstream of pre-BCR and BCR activation, mainly by facilitating calcium flux.
The BTKbase has documented over 600 distinct mutations in 1100 patients, many
of which affect Btk protein folding or stability. Despite the consistent
disruption in B cell development in XLA patients, variability exists in
susceptibility to infections, age at diagnosis, number of circulating B cells,
and serum immunoglobulin levels. Interestingly, the Btk mutation in xid mice
and mice with targeted Btk disruption results in a milder form of B cell
immunodeficiency compared to most XLA patients. Future research may uncover how
individual genetic variations could either mitigate or amplify the effects of
BTK mutations.
Two other groups of immunodeficiencies primarily affect later stages of B cell development. Individuals with Common Variable Immune Deficiency (CVID) have low serum immunoglobulin levels and increased infection susceptibility, along with variable reductions in memory B cells, class switch recombination (CSR), and B cell activation. Mutations in several genes, such as ICOS (activated T-cell stimulatory molecule), CD19 (B-cell surface receptor), and TACI (TNF receptor superfamily member), have been found in CVID patients, but these mutations account for only 10% to 15% of cases. The age at diagnosis can range from 3 to 78 years, influenced by a combination of genetic and environmental factors.
A second
group includes individuals with hyper-IgM syndrome, characterized by recurrent
infections, elevated serum IgM levels, low levels of other immunoglobulin
isotypes, and an overall failure of B cells to undergo CSR and somatic
hypermutation (SHM). The most common mutation associated with this condition is
in CD154 (CD40 ligand), found on activated T cells, which is inherited in an
X-linked manner. Rare cases involve mutations in CD40, IKK-gamma/NEMO, and
uracil-DNA glycosylase. The essential role of activation-induced cytidine
deaminase (AID) in developing a functional immunoglobulin repertoire is
highlighted by the fact that an autosomal recessive deficiency in AID also
results in hyper-IgM syndrome.
3.
Failure of Central Tolerance
Central
tolerance is achieved through the negative selection of self-reactive B cells
in the bone marrow. When this process is defective, self-reactive B cells can
escape into the peripheral blood and produce autoantibodies that target the
body’s own tissues. This failure in central tolerance can result in various
autoimmune conditions. For example, in systemic lupus erythematosus (SLE),
defects in central tolerance led to the production of autoantibodies against
nuclear antigens, contributing to widespread tissue damage and inflammation.
4. Infection Risk:
Proper B cell selection is essential for creating a
diverse and functional B cell population. When this process is compromised,
either due to defects in positive or negative selection, it can result in a
reduced ability to produce effective antibodies. This decreased antibody
production impairs the immune system's ability to recognize and respond to
infections. Individuals with such defects may experience a higher frequency and
severity of infections because their immune system lacks the necessary B cells
to effectively combat pathogens.
5. Immune
Dysregulation:
Role
of B Cell Selection in Immune System:
1. Preventing Autoimmunity
B cell
selection is essential for preventing autoimmune diseases, where the immune
system mistakenly targets the body’s own tissues. During their development, B
cells that bind strongly to self-antigens are usually eliminated or inactivated
through mechanisms like clonal deletion, receptor editing, or anergy. This
process prevents self-reactive B cells from maturing and entering circulation,
which would otherwise produce antibodies against the body’s own cells,
potentially leading to autoimmune diseases such as lupus, rheumatoid arthritis,
or type 1 diabetes. By removing these harmful B cells, the selection process
acts as a critical defense against autoimmunity, ensuring that only
non-self-reactive B cells continue to develop and function.
2.Ensuring Immune Competence
Positive
selection is crucial for ensuring that the immune system is both diverse and
capable of responding effectively to a wide range of pathogens. During B cell
development, V(D)J recombination generates a vast array of B cell receptors
(BCRs), each with a unique specificity for different antigens. Positive
selection tests these receptors to ensure they are functional and can bind to
antigens. Only B cells with functional BCRs receive survival signals and
continue developing. This step is vital because it ensures that the immune
system has a broad repertoire of B cells ready to recognize and respond to
various pathogens, including bacteria, viruses, fungi, and parasites. Without
this diversity, the immune system would be less effective in combating the wide
array of threats it faces.
3. Maintaining Immune Homeostasis
B cell
selection also plays a key role in maintaining the overall balance, or
homeostasis, of the immune system. This balance is critical to ensuring that
the immune system is neither overly aggressive nor underactive. If B cells were
allowed to proliferate without control, especially those with self-reactive or
overly active BCRs, it could result in an immune system that is too aggressive,
leading to autoimmune diseases. On the other hand, if the selection process
were too stringent or ineffective, it could result in too few functional B
cells, leading to immunodeficiency, where the body cannot mount an adequate
defense against infections. B cell selection helps maintain this delicate
balance, ensuring that the immune system is strong enough to fight infections
while being restrained enough to avoid attacking the body’s own tissues.
4. Supporting
Vaccination and Immune Memory
Conclusion
B cell
selection is fundamental to the immune system for several key reasons. Firstly,
it is essential for preventing autoimmune diseases. The selection process
filters out B cells that could potentially attack the body's own tissues,
thereby maintaining self-tolerance and protecting against conditions like
lupus, rheumatoid arthritis, and type 1 diabetes.
Additionally,
B cell selection is crucial for developing a diverse and functional array of B
cells capable of recognizing and responding to a broad spectrum of pathogens.
Positive selection ensures that only B cells with functional receptors that can
effectively bind to antigens are retained, equipping the immune system with the
capability to address various infections.
Furthermore,
B cell selection helps maintain immune balance by preventing the immune system
from becoming too aggressive, which could lead to autoimmunity, or too weak,
which could result in immunodeficiency. This balance is critical for optimal
immune function and overall health. Finally, the selection process supports the
effectiveness of vaccines and the formation of long-term immune memory. By
selecting B cells that respond to specific vaccine antigens, the immune system
creates a memory pool that provides lasting protection against diseases.
Reference:
· Monroe, J. G., Bannish, G., Fuentes-Panana, E. M., King, L. B., Sandel, P. C., Chung, J., & Sater, R. (2003). Positive and negative selection during B lymphocyte development. Immunologic research, 27(2-3), 427–442.
· Chen, J. W., Schickel, J. N., Tsakiris, N., Sng, J., Arbogast, F., Bouis, D., Parisi, D., Gera, R., Boeckers, J. M., Delmotte, F. R., Veselits, M., Schuetz, C., Jacobsen, E. M., Posovszky, C., Schulz, A. S., Schwarz, K., Clark, M. R., Menard, L., & Meffre, E. (2022). Positive and negative selection shape the human naive B cell repertoire. The Journal of clinical investigation, 132(2), e150985. https://doi.org/10.1172/JCI150985
· https://www.osmosis.org/learn/B-cell_development
· Subhash Chandra Parija, Textbook of Microbiology and Immunology, 3rd edition (2016).
· Kuby Owen, Immunology, 7th edition (2013).
· Abbas, Lichtman, and Pillai, Cellular and Molecular Immunology, 7th edition (2011)
· Tarlinton Nature Reviews Immunology 6, 785-790 (October 2006).· Dr. S.K.Gupta, Essentials of Immunology, 1 edition (2014)